Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Impact of obesity, structural severity and their combination on the efficacy of viscosupplementation in patients with knee osteoarthritis.

Conrozier T, Eymard F, Chouk M, Chevalier X.

BMC Musculoskelet Disord. 2019 Aug 17;20(1):376. doi: 10.1186/s12891-019-2748-0.

2.

How to treat osteoarthritis in obese patients?

Conrozier T.

Curr Rheumatol Rev. 2019 Jun 24. doi: 10.2174/1573397115666190625105759. [Epub ahead of print]

PMID:
31241017
3.
4.

Hyaluronan derivative HYMOVIS® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: data from MOKHA study.

Henrotin Y, Bannuru R, Malaise M, Ea HK, Confavreux C, Bentin J, Urbin-Choffray D, Conrozier T, Brasseur JP, Thomas P, Hick AC, Marinello A, Giordan N, Richette P.

BMC Musculoskelet Disord. 2019 Jun 18;20(1):293. doi: 10.1186/s12891-019-2667-0.

5.

Multicenter, Prospective, Controlled Double-Blind Study Comparing Fib-19-01, A Phytotherapy Treatment, To A Dietary Supplement And To Conventional Care In Patients Suffering From Fibromyalgia.

Barmaki M, Maindet-Dominici C, Nizard J, Baron D, Russ I, Fardellone P, Ginies P, Marc JF, Conrozier T, Bertin P.

Altern Ther Health Med. 2019 Jul;25(4):46-53.

PMID:
31202211
6.

Safety and Predictive Factors of Short-Term Efficacy of a Single Injection of Mannitol-Modified Cross-Linked Hyaluronic Acid in Patients with Trapeziometacarpal Osteoarthritis. Results of a Multicentre Prospective Open-Label Pilot Study (INSTINCT Trial).

Dauvissat J, Rizzo C, Lellouche H, Porterie J, Melac-Ducamp S, Locquet V, Travers V, Maillet B, Conrozier T.

Clin Med Insights Arthritis Musculoskelet Disord. 2018 Jun 21;11:1179544118782901. doi: 10.1177/1179544118782901. eCollection 2018.

7.

EUROVISCO Guidelines for the Design and Conduct of Clinical Trials Assessing the Disease-Modifying Effect of Knee Viscosupplementation.

Henrotin Y, Chevalier X, Raman R, Richette P, Montfort J, Jerosch J, Baron D, Bard H, Carrillon Y, Migliore A, Conrozier T.

Cartilage. 2018 Jul 1:1947603518783521. doi: 10.1177/1947603518783521. [Epub ahead of print]

PMID:
29972025
8.

EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis.

Conrozier T, Monfort J, Chevalier X, Raman R, Richette P, Diraçoglù D, Bard H, Baron D, Jerosch J, Migliore A, Henrotin Y.

Cartilage. 2018 Jun 1:1947603518783455. doi: 10.1177/1947603518783455. [Epub ahead of print]

PMID:
29926748
9.

Systematic clinical evidence review of NASHA (Durolane hyaluronic acid) for the treatment of knee osteoarthritis.

Leighton R, Fitzpatrick J, Smith H, Crandall D, Flannery CR, Conrozier T.

Open Access Rheumatol. 2018 May 21;10:43-54. doi: 10.2147/OARRR.S162127. eCollection 2018. Review.

10.

Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering from Knee Osteoarthritis: Recommendations from the EUROpean VIScosupplementation COnsensus Group (EUROVISCO).

Raman R, Henrotin Y, Chevalier X, Migliore A, Jerosch J, Montfort J, Bard H, Baron D, Richette P, Conrozier T.

Cartilage. 2018 Jul;9(3):263-275. doi: 10.1177/1947603517693043. Epub 2017 Feb 1.

11.

Hip Inflammation MRI Scoring System (HIMRISS) to predict response to hyaluronic acid injection in hip osteoarthritis.

Deseyne N, Conrozier T, Lellouche H, Maillet B, Weber U, Jaremko JL, Paschke J, Epstein J, Maksymowych WP, Loeuille D.

Joint Bone Spine. 2018 Jul;85(4):475-480. doi: 10.1016/j.jbspin.2017.08.004. Epub 2017 Sep 8.

PMID:
28893678
12.
13.

Is the Addition of a Polyol to Hyaluronic Acid a Significant Advance in the Treatment of Osteoarthritis?

Conrozier T.

Curr Rheumatol Rev. 2018;14(3):226-230. doi: 10.2174/1573397113666170710115558. Review.

PMID:
28699498
14.

Obesity and radiological severity are associated with viscosupplementation failure in patients with knee osteoarthritis.

Eymard F, Chevalier X, Conrozier T.

J Orthop Res. 2017 Oct;35(10):2269-2274. doi: 10.1002/jor.23529. Epub 2017 Feb 9.

15.

Predictors of response to viscosupplementation in patients with hip osteoarthritis: results of a prospective, observational, multicentre, open-label, pilot study.

Eymard F, Maillet B, Lellouche H, Mellac-Ducamp S, Brocq O, Loeuille D, Chevalier X, Conrozier T; Osteoarthritis Group of the French Society of Rheumatology and of the French Research Group in Interventional Rheumatology.

BMC Musculoskelet Disord. 2017 Jan 6;18(1):3. doi: 10.1186/s12891-016-1359-2.

16.

Imaging Guidance Improves the Results of Viscosupplementation with HANOX-M-XL in Patients with Ankle Osteoarthritis: Results of a Clinical Survey in 50 Patients Treated in Daily Practice.

Bossert M, Boublil D, Parisaux JM, Bozgan AM, Richelme E, Conrozier T.

Clin Med Insights Arthritis Musculoskelet Disord. 2016 Nov 22;9:195-199. eCollection 2016.

17.

Standardized Follow-up of Patients with Symptomatic Knee Osteoarthritis Treated with a Single Intra-articular Injection of a Combination of Cross-Linked Hyaluronic Acid and Mannitol.

Conrozier T, Bozgan AM, Bossert M, Sondag M, Lohse-Walliser A, Balblanc JC.

Clin Med Insights Arthritis Musculoskelet Disord. 2016 Sep 25;9:175-9. doi: 10.4137/CMAMD.S39432. eCollection 2016.

18.

Safety and efficacy of intra-articular injections of a combination of hyaluronic acid and mannitol (HAnOX-M) in patients with symptomatic knee osteoarthritis: Results of a double-blind, controlled, multicenter, randomized trial.

Conrozier T, Eymard F, Afif N, Balblanc JC, Legré-Boyer V, Chevalier X; Happyvisc Study Group.

Knee. 2016 Oct;23(5):842-8. doi: 10.1016/j.knee.2016.05.015. Epub 2016 Jun 25.

PMID:
27353769
19.

Steroids, lidocain and ioxaglic acid modify the viscosity of hyaluronic acid: in vitro study and clinical implications.

Conrozier T, Patarin J, Mathieu P, Rinaudo M.

Springerplus. 2016 Feb 24;5:170. doi: 10.1186/s40064-016-1762-z. eCollection 2016.

20.

Optimizing the effectiveness of viscosupplementation in non-knee osteoarthritis.

Conrozier T.

Joint Bone Spine. 2016 Jan;83(1):1-2. doi: 10.1016/j.jbspin.2015.08.009. Epub 2015 Oct 6. No abstract available.

PMID:
26453104

Supplemental Content

Loading ...
Support Center